日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting

FINE-REAL研究的首批中期结果:一项前瞻性、非干预性4期研究,旨在深入了解非奈利酮在常规临床应用中的用途和安全性。

Nicholas, Susanne B; Correa-Rotter, Ricardo; Desai, Nihar R; Guo, Lixin; Navaneethan, Sankar D; Pantalone, Kevin M; Wanner, Christoph; Hamacher, Stefanie; Fatoba, Samuel T; Horvat-Broecker, Andrea; Garreta-Rufas, Antonio; Gay, Alain; Merz, Martin; Wheeler, David C

The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease

导致不遵守蛋白尿检测指南的因素以及未能识别慢性肾脏病的临床和经济影响

Groehl, Franziska; Garreta-Rufas, Antonio; Meredith, Kimberley; Harris, James; Rossing, Peter; Hobbs, F D Richard; Wanner, Christoph